Mounjaro®
Starting from £179.99/mo
Start journey Learn moreGetting the Mounjaro injection in the UK legally means one thing: a valid prescription from a registered prescriber, following a proper clinical assessment. There is no other route. Mounjaro (tirzepatide) is a Prescription-Only Medicine — a prescriber decides suitability based on your individual health picture, not a checkout form. That assessment can happen through the NHS or through a regulated private service like nume, a GPhC-registered online pharmacy with its own dispensing facility. Either way, the medicine does not and cannot change hands without clinical sign-off first.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Your first real decision is whether to pursue Mounjaro through the NHS or privately. Both routes lead to the same medicine, but they work very differently in practice.
On the NHS, tirzepatide is being phased in under strict eligibility thresholds, NICE's appraisal TA1026 currently limits access to adults with a BMI of 40 or above plus four or more qualifying conditions, with broader cohorts coming in stages over the next two years. GP practices began prescribing under the new contract from April 2026, but participation is optional. Some practices are involved; many are not yet. Waiting times vary significantly by area. For a detailed breakdown of how the NHS rollout applies to you, it is worth reading before assuming you qualify.
Private treatment through a regulated online pharmacy removes the waiting list. A prescriber still assesses you fully, but the eligibility criteria reflect the licensed indications in the medicine's summary of product characteristics: adults with a BMI of at least 30, or 27 and above alongside a weight-related health condition such as high blood pressure, type 2 diabetes, high cholesterol or obstructive sleep apnoea. If you are ready to move forward, you can start the Mounjaro process with us now and a prescriber will review your answers the same day. BMI alone is not a rubber stamp, the prescriber weighs everything.
Lower BMI thresholds apply for some ethnic backgrounds under UK guidance. Your prescriber will factor this in during the assessment.
Once you decide on the private route, the process at a regulated service is straightforward. At nume, it runs like this.
You complete a clinical questionnaire online. A GPhC-registered Independent Prescriber reads your answers the same day, not software, a named clinician. If your answers flag anything that needs clarification, they follow up. You then verify your identity with a photo ID and confirm your weight on a short video call. That step matters: it protects you and it is why we can be confident we are prescribing for the right person.
If the prescriber is satisfied you are clinically suitable, they issue a Mounjaro prescription and our GPhC-registered pharmacy dispenses it. Order before 12pm on a working day and it leaves the same afternoon. A DPD tracking notification arrives on your phone; the box itself is plain and unbranded. Inside, the KwikPen is sealed and cold-chain compliant, sourced through the licensed UK supply chain. For more on how dispensing works, see our pharmacy page.
Every repeat order goes through the same clinical re-review. There are no subscriptions and no automatic renewals.
Mounjaro's rise in popularity has brought a parallel rise in unregulated sellers. The MHRA has publicly warned about counterfeit weight-loss pens circulating online and through social media, in late 2025 its enforcement team raided the first UK site found to be manufacturing fake tirzepatide pens. Fake pens have been found to contain insulin and other substances entirely different from the labelled content. The consequences can be serious.
The safe check is simple. Every legitimate UK online pharmacy must be registered with the General Pharmaceutical Council. You can look up any pharmacy by name or registration number at the GPhC register, nume's registration number is 9012878. If a seller is not on that register, do not order from them.
Red flags worth knowing: offers of these medicines without a clinical consultation, prices that seem dramatically below the rest of the market, discount codes from unfamiliar accounts on social platforms, and no visible GPhC or MHRA registration. Report anything suspicious at the MHRA's Yellow Card site, which handles both side-effect reports and suspect-seller concerns.
For a wider look at what the buying landscape online looks like and what separates legitimate services from the rest, that page covers it in detail.
People sometimes assume that meeting a BMI threshold is sufficient and the prescription follows automatically. It is not quite that simple, and knowing what a prescriber considers helps you approach the consultation honestly.
Beyond BMI, your prescriber will look at current medications (some interact with tirzepatide), relevant medical history (including any personal or family history of thyroid conditions), and whether you have any conditions that would make treatment unsuitable. Pregnancy, breastfeeding and actively trying to conceive are contraindications. The medicine is not licensed for under-18s.
Women using oral contraceptives who start tirzepatide should use an additional non-oral method of contraception for the first four weeks of treatment and for four weeks after each dose increase, because the absorption of the pill may be affected, as noted in NHS England's guidance on weight management injections. Your prescriber will cover this with you.
The assessment is also the right moment to discuss any previous weight-loss treatment. Transfer patients can continue their current dose with appropriate evidence rather than restarting from scratch. If you have been on tirzepatide before or are transferring from another service, that is worth mentioning in your consultation, and our guide on how to buy a tirzepatide injection through a regulated UK service explains what to expect at each stage. You can read more about the full treatment picture on our Mounjaro overview page or explore all available weight-loss treatments if you are still weighing your options.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.